Ditchcarbon
  • Customers
  1. Organizations
  2. Grace Therapeutics, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Grace Therapeutics, Inc.

Company website

Grace Therapeutics, Inc., a pioneering biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for neurological disorders. Founded in 2015, the company has made significant strides in advancing its proprietary drug delivery systems, particularly in the treatment of conditions such as epilepsy and other central nervous system disorders. With a commitment to enhancing patient outcomes, Grace Therapeutics offers unique formulations that improve the bioavailability and efficacy of existing medications. Their cutting-edge approach has positioned them as a leader in the biopharmaceutical industry, garnering recognition for their contributions to drug development. As they continue to expand their operational reach, Grace Therapeutics remains dedicated to transforming the landscape of neurological treatment through science and innovation.

DitchCarbon Score

How does Grace Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Grace Therapeutics, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Grace Therapeutics, Inc.'s reported carbon emissions

Grace Therapeutics, Inc., headquartered in the US, currently does not have any reported carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there are no emissions or reduction initiatives available, it is unclear how Grace Therapeutics, Inc. is addressing its carbon footprint or contributing to climate action within its industry. The lack of data may suggest an opportunity for the company to develop and communicate its climate commitments more effectively in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Grace Therapeutics, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Grace Therapeutics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Grace Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Enzymotec Ltd.

IL
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Bioriginal

CA
•
Health and social work services (85)
Updated 14 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Mitsubishi Tanabe Pharma

JP
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Boehringer Ingelheim

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Reata Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250809.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy